Beyond its prognostic and diagnostic uses, the increase of CXCR4 expression is a critical driver of therapy resistance by regulating DNA damage repair, cancer stemness, and immune evasion, all of which impair response to chemotherapy, radiotherapy, and ICIs. This evidence concerns the gene CXCR4 and cancer.